… ulcer disease (PUD) in liver cirrhosis (LC) and chronic hepatitis has not been established.
The aim of this study was to assess the role of portal hypertension … 455 hepatic vein pressure …

… monitoring of the effects of pharmacologic therapy in portal hypertension. The ability of the
… effects of vasoactive drugs currently used in the medical treatment of portal hypertension. In …

… Although the addition of ISMN to NSBB has a greater portal pressure-reducing effect[53],
in … , but has a higher rate of side-effects[54]. Sclerotherapy decreases rebleeding rates and …

… portal hypertension are caused by varices,6 but bleeding may also stem from peptic ulcer
disease… care setting because of its side effects, including hypertension, bradycardia, coronary …

… treatment of portal hypertension and to foster future collaborative research projects. The portal
hypertension-… topic related to evaluation and treatment of portal hypertension. The chair of …

… PHG increases in frequency with more severe portal hypertension, advanced liver disease,
longer liver disease duration, … The effect of glucagon occurred only in rats with preexisting …

… of portal hypertension has opened the scene to pharmacological treatments, resulting in a
dramatic change in the therapeutic approach to portal hypertension… the treatment effect was in …

… It has been shown that the addition of ISMN to either propranolol 41 or nadolol 71 has a
synergistic effect in lowering portal pressure. In a recent long-term randomized, controlled trial, …

… reverse the adverse hemodynamic consequences of established portal hypertension ( 13 ).
… Weiss lesions, portal hypertensive gastropathy, and peptic ulcer disease. Figure 31.3 shows …

This paper reports the incidence and natural history of macroscopic gastritis in a series of
127 consecutive patients with portal hypertension of various aetiologies. Gastritis was …